ESR(01821.HK)收購上海張江生命科學研發產業園 涉2.68億人幣
ESR(01821.HK)宣布,與合作夥伴收購位於上海張江的生命科學研發產業園,作價達到2.68億元人民幣(約4,000萬美元)。
該產業園前身為「張江NEO」,位於上海張江高科技開發園區(張江藥谷二期),總建築面積為8,940平方米,由兩座4至5層的製藥研發實驗室和辦公室空間組成,按租賃建築面積計算,超過90%的租戶為領先的生物醫藥類公司,聚焦於涵蓋大、小分子的腫瘤類、免疫類和其他有重大未滿足醫療需求的疾病領域的創新藥物研發,並提供相關生命科學領域原料與技術的解決方案。
ESR 聯合創始人兼聯席首席執行官沈晉初及Stuart Gibson 表示,很高興將新經濟地產版圖擴至生命科學領域,進一步拓闊ESR房地產投資解決方案的範圍,將致力滿足生物製藥行業日益增長的需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.